Redeye concludes that Railcare had a promising start to the year with higher sales and earnings than we expected. General market conditions remain favorable, and we see good opportunities for continued profitable growth within Railcare’s main business segments. We are leaving our forecasts and valuation basically unchanged.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Railcare - Q1- Well on Track

© Modular Finance, source Nordic Press Releases